We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Ovarian Transplant Technique Could Preserve Fertility in Cancer Patients

By HospiMedica International staff writers
Posted on 13 Jul 2009
A new two-step method for ovarian transplant has shown excellent results in women whose ovaries had been frozen due to cancer treatment. More...


Researchers at Limoges University Hospital (France) divided the transplant process into two separate procedures. They first grafted small pieces of the frozen ovarian tissue in the ovarian and peritoneal areas three days before the actual organ transplant; this encouraged the growth of blood vessels, and paved the way for the actual transplant. By the two-step process, the ovary was able to become fully functional in a shorter time scale than would be possible if all the tissue were to be transplanted at the same time. The researchers have so far utilized the new technique in two patients who had been treated for cancer and had their ovaries frozen. The first patient had been menopausal for two years, as a result of treatment for sickle cell anemia. After transplanting her own ovarian tissue, she started ovulating four months later. She became pregnant naturally six months after transplantation, and gave birth during June 2009.

The second patient had been treated for periarteritis nodosa, an inflammation of medium-sized arteries, which become swollen and damaged from attack by rogue immune cells. She suffered menopause for eight and a half years before transplantation, but after transplanting half of the frozen ovary, she recovered spontaneous ovulation in four months. Since her right fallopian tube had been destroyed by the ovarian retrieval, the researchers decided to collect the highest number of eggs they could, and carried out an in vitro fertilization (IVF) procedure on the patient. Six months after the operation, the researchers transferred two blastocysts to the patient, who unfortunately developed an ectopic pregnancy; however, she is now pregnant again. The study was presented at the annual meeting of the European Society of Human Reproduction and Embryology, held during June-July 2009 in Amsterdam (The Netherlands).

"This is the first time that a pregnancy has been obtained after a ten year gap between ovarian cryopreservation and grafting. We believe that it represents a considerable advance on the methods of ovarian transplantation used until now, not least because we are able to obtain large numbers of oocytes,” said lead author and study presenter Pascal Piver, M.D., manager of the IVF Centre at Limoges University Hospital. "We hope that it will enable more young patients who have been cured of cancer to regain their reproductive health and become pregnant with their own children.”

Related Links:
Limoges University Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.